IFLR1000

CVS Health $12.7 billion acquisition of Omnicare

18/8/2015
Acquisition finance, Public acquisition
Select tab

$ 12.7 billion

Completed

18/8/2015

Overview:

  • CVS Health has completed its $12.7 billion acquisition of fellow pharmaceutical services provider Omnicare.
  • The transaction figure includes $2.3 billion of Omnicare debt.
  • The deal was first announced in May, 2015.
  • Sullivan & Cromwell (Matthew Hurd, Brian Hamilton) advised CVS.
  • White & Case (Morton Pierce, Chang-Do Gong, Robert Chung) advised Omnicare.
  • Shearman & Sterling (Gus Atiyah, Jonathan DeSantis) represented Omnicare financial advisers BofA Merrill Lynch and Centerview Partners.

Kurt Stumpo - Journalist - North America and the Caribbean

Jurisdiction:

United States

Deal types:

Acquisition finance
Public acquisition

Practice area:

M&A

Governing law:

United States

Industry sectors:

Consumer goods and services
Pharmaceuticals and life sciences

Firms:
Shearman & Sterling

Party: Centerview Partners (Financial adviser)

Party: Bank of America Merrill Lynch (Financial adviser)

Lawyer: Gus Atiyah

Sullivan & Cromwell

Party: CVS Health (Acquirer)

Lawyers: Brian Hamilton, Matthew Hurd

White & Case

Party: Omnicare (Target)

Lawyers: Chang-Do Gong, Morton Pierce, Robert Chung

Related deals